Reduced expression levels of antioxidants such as catalase, mitochondrial manganese superoxide dismutase (MnSOD), CuZnSOD, and reduced glutathione (GSH), not surprisingly, have been shown in human prostate cancer patient specimens, including tissue samples [27,28,29]. This evidence concerns the gene CAT and prostate carcinoma.